Blood tests for tau, a key biomarker of Alzheimer’s disease, may predict dementia risk, a new study found. The best way to ...
A commercial assay that measures eMTBR-tau may be an alternative to tau PET imaging in diagnosing Alzheimer’s disease, according to data presented at the Alzheimer’s Association International ...
Research involving a Rutgers professor sheds new light on the biological basis of schizophrenia by directly measuring ...
Prostate cancer is one of the most common cancers affecting men worldwide. However, planning personalized radiotherapy in the ...
Diranersen demonstrated efficacy across all studied doses at 18 months, with consistent results across multiple prespecified clinical endpoints; the 60 mg dose showed the strongest response with ...
New Mexico Cancer Center will become the first healthcare provider in the state to offer estrogen receptor (ER)-targeted PET ...
Siemens Healthineers has announced a new radiopharmacy in Dunstable, UK. Designed as the UK’s first 8X radiopharmacy, the manufacturing facility will deliver output at eight times the capacity of a ...
A second scan using prostate-specific membrane antigen positron emission tomography changed treatment plans for nearly half of patients with recurrent prostate cancer whose initial scan was negative, ...
Guidelines are now available to optimize imaging for the evaluation and surveillance of cutaneous squamous cell carcinoma, a document that is expected to inform future guidelines.
A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first ...
Bastrop officials hope new microchip scanners will help reunite more lost pets with their owners faster and reduce trips to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results